From Diagnosis to Treatment - Part 3 of 4, Diagnosis of Breast Cancer with H&E and Immunohistochemistry Stains
In the case of Breast Cancer, the patient’s cancer is usually detected by a mammogram or palpitation of an experienced Physician. However, these first indications that something is wrong must be confirmed by a more scientific approach. Usually what follows is an actual biopsy; a sample of the tissue in question is removed from the person. Once a tumor is confirmed from the biopsy, then a more radical surgical approach may be necessary or other treatments are performed. Part 3 of the series addresses the importance of proper H&E/ICH sections and staining for diagnosis of breast tumors. A view of optimization and controls for prognostic markers will be examined, and brief overview of IHC diagnosis and treatment will presented.
If you have viewed this educational webinar, training or tutorial on Knowledge Pathway and would like to apply for continuing education credits with your certifying organization, please download the form to assist you in adding self-reported educational credits to your transcript.Apply for self-reported educational credits
Discuss the importance of good H&E /IHC sections, and differences in the pathologist’s evaluation of core versus whole-section specimens.
- Understand the differential diagnosis of types of breast tumors.
- To view a good optimization of the antibody as an essential part of laboratory practice.
- Examine a variety of controls for prognostic (graded) IHC markers such as ER/PR/